Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth.
[primary hyperoxaluria type 1]
Cure
of
the
metabolic
defect
in
primary
hyperoxaluria
type
1
(
PH
1
)
is
possible
with
liver
transplantation
(
LTx
)
.
Preemptive
LTx
(
PLTx
)
was
promoted
to
prevent
chronic
kidney
disease
due
to
nephrocalcinosis
and
urolithiasis
.
However
,
timing
of
this
procedure
is
difficult
in
view
of
the
heterogeneity
of
PH
1
and
effective
conservative
treatment
.
Combined
liver
-kidney
transplantation
(
LKTx
)
is
able
to
cure
metabolic
defect
and
replace
renal
function
at
the
same
time
and
is
effective
and
indicated
for
patients
with
or
approaching
end-
stage
renal
disease
(
ESRD
)
.
Sometimes
a
sequential
approach
for
LKTx
(
first
liver
,
then
kidney
)
has
been
recommended
.
We
report
on
13
patients
with
PH
1
since
1995
who
underwent
transplantation
procedures
in
our
center
for
PH
1
at
a
median
age
of
4
.
7
(
range
1
.
4
-
8
.
9
)
years
.
The
first
two
patients
,
planned
for
a
sequential
strategy
,
died
early
after
LTx
because
of
infectious
complications
.
Four
patients
underwent
PLTx
at
a
median
glomerular
filtration
rate
of
65
(
range
27
-
98
)
mL
/
min
/
1
.
73
m
/
day
(
Hoppe
et
al
.
,
Pediatr
Nephrol
1996
;
10
:
488
)
,
and
three
patients
still
have
sufficient
residual
renal
function
after
a
follow-up
of
median
11
.
6
years
.
Seven
patients
with
ESRD
received
a
combined
LKTx
,
including
four
with
infantile
oxalosis
,
and
three
weighing
less
than
10
kg
.
There
was
no
mortality
and
catch-up
growth
was
observed
in
most
patients
.
In
summary
and
conclusion
,
transplantation
procedures
are
challenging
in
PH
1
,
but
our
results
including
growth
data
are
encouraging
.
PLTx
remains
an
option
despite
the
difficulties
in
timing
the
procedure
.
LKTx
is
indicated
for
patients
with
ESRD
and
is
possible
even
in
patients
with
infantile
oxalosis
and
may
improve
longitudinal
growth
.
Diseases
Validation
Diseases presenting
"for patients with esrd"
symptom
primary hyperoxaluria type 1
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom